永安药业多项举措完善公司治理，经营范围与组织架构迎来调整

Core Points - Yong'an Pharmaceutical Co., Ltd. announced adjustments to its business scope and board composition to enhance governance efficiency and adapt to operational needs [1][2] - The company plans to expand its business scope to include drug wholesale, import and export, and production and sales of pharmaceutical excipients, among other activities [1] - The board of directors will increase from 6 to 7 members, adding one employee representative director and one vice chairman, while the supervisory board will be abolished [1][2] Business Scope Adjustments - The previous business scope included the production and sales of APIs, food additives, and feed additives, as well as self-produced and sold products like ethylene oxide [1] - The new scope will include licensed projects such as drug wholesale and pharmaceutical excipients, along with general projects like chemical product production and technical services [1] Governance Enhancements - The company will revise parts of its articles of association, including increasing the number of board members and abolishing the supervisory board [1][2] - Eleven governance documents will be revised or established, including rules for shareholder meetings and board meetings, with three requiring shareholder approval [2]